Best Life Sciences Platforms and Tools Companies in Ireland
The 41 best Life Sciences Platforms and Tools companies in Ireland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Sublimity Therapeutics.
- ResearchAndMarkets.com
- Precedence Research
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Ireland
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Sublimity Therapeutics Developer of drugs for gastrointestinal and immunological diseases | $64M | 99 mo ago | 50 | — | — | Deadpooled | 44 patents Lipid-based oral formulations for cyclosporine immunosuppressant delivery | — |
| 2 | Avectas Provider of non-viral cell engineering technology platform for drug discovery | $33M | 76 mo ago | 35 | Michael Maguire Co-Founder & CEO | WebflowGSAPAmazon Web Services+12 | Series C | 102 patents Non‑viral intracellular delivery platforms for biomolecules via membrane permeabilization and flow‑through systems | 1 partnership |
| 3 | DS Biopharma Provider of a lipid technology platform for atopic dermatitis | $16M | 174 mo ago | 10 | Ronan Lambe Co-Founder | — | Series A | 69 patents Patents concentrated in health & consumer products | — |
| 4 | Kastus Developer of antiviral and antimicrobial surface coatings | $12M | 49 mo ago | 9 | — | — | Series A | — | — |
| 5 | Biosortia Natural Product Drug Discovery from unculturable aquatic microorganisms for the treatment of Cancer, CNS and… | $10M | 81 mo ago | — | Ross Youngs Interim CEO | — | Series A | — | — |
| 6 | Biosensia Point-of-care in vitro diagnostics for immunoassays | $10M | 134 mo ago | 17 | — | — | Acquired | — | — |
| 7 | RemedyBio Provider of personalised, cell based, autologous and anti-tumour therapy | $9M | 51 mo ago | 18 | Daniel Crowley CEO | — | Series A | — | — |
| 8 | GenCell Biosystems Developer of innovative biological testing instruments | $8M | 158 mo ago | 60 | Kieran Curran Founder | — | Acquired | 91 patents Magnetic bead‑based nucleic acid extraction and on‑chip genomic analysis devices | — |
| 9 | Akkure Provider of a blockchain technology based online platform for genomic data analytics | $3M | 45 mo ago | 9 | Amy Hollingworth Co-Founder | — | Seed | — | — |
| 10 | SiriusXT 3D imaging of biological cells using X-rays | $3M | 68 mo ago | 23 | — | WordPressMySQLPHP+21 | Series A | — | — |
| 11 | GlycoSeLect Provider and developer of recombinant prokaryotic lectins | $2M | 77 mo ago | 5 | — | — | Series A | — | — |
| 12 | Algae Health Produces bio actives from microalgae | $1M | 163 mo ago | 11 | Edward McHugh Founder & MD | — | Deadpooled | 3 patents Algal cultivation systems and photobioreactor technologies for biomass production | — |
| 13 | Oculer Provider of bacteria detection services for milk and associated products | $1M | 123 mo ago | 8 | Brian Byrne CEO | — | Series A | 4 patents Fluorescence microtiter plate readers for real‑time analyte concentration monitoring | — |
| 14 | Advanced Microplates Developing multi-well assay plates for better control and reproducibility | $1M | 178 mo ago | 2 | — | — | Deadpooled | — | — |
| 15 | Cell Stress Discoveries Provider of biomarker discovery for ER stress disorders | $1M | 82 mo ago | — | Afshin Samali Co-Founder | — | Funding Raised | — | — |
| 16 | Cellix Manufacturer of microfluidics, biochips, high-throughput cell membrane and gene editing technology | $1M | 92 mo ago | 7 | — | Cart FunctionalityWix eCommerceWix+18 | Acquired | 44 patents Microfluidic cell transfection and flow‑cytometry platforms for high‑throughput analysis | — |
| 17 | PolyPico Technologies Ultra-low volume liquid handling solutions | $480K | 82 mo ago | 9 | Gabriel Leen Co-Founder | WordPressMySQLRedis+19 | Funding Raised | — | — |
| 18 | Aran Biomedical Provider of solutions for implantable medical devices | $289K | 127 mo ago | 59 | — | WordPressMySQLPHP+32 | Acquired | 18 patents Low-profile composite coverings for medical balloons, catheters, and surgical fabrics. | — |
| 19 | ImmunoGrow Developer of cell-based immunotherapeutics | $114K | 110 mo ago | — | Rory Dunne CEO | — | Deadpooled | — | — |
Top 12 Life Sciences Platforms and Tools companies in Ireland
#1
Series A · Dublin, Leinster · founded 2014 · 9 employees$11.8Mraised▾
Developer of antiviral and antimicrobial surface coatings. Kastus has developed visible light-activated, photocatalytic antimicrobial coatings for Glass and Ceramics and novel antimicrobial zeolite additives for use on Metals, Paints, and Plastics. The company claims that this proprietary technology has been engineered to provide a 99.99% reduction in harmful bacteria and fungi including antibiotic-resistant superbugs MRSA and E. Coli.
- Jul 2022Grant (prize money)$51.1K
- Jun 2021Series A$6.7M
- Aug 2020Grant (prize money)$1.9M
- Jun 2020Grant (prize money)$1.8M
#2
Seed · Dublin, Leinster · founded 2016 · 9 employees$3.4Mraised▾
Akkure is an online platform for genomics data analytics. The platform enables the user to control, manage data or provide rewards for sharing data. It also enables researchers to connect with organizations to order DNA test kits for genomics sequencing, receive results, and analyze genomics data. The company uses blockchain-based technology in order to share and manage research data analytics.
- Nov 2022Grant (prize money)$718.1K
- 2021Seed$1.9M
- Jan 2021Seed$1.4M
#3
Series A · Dublin, Leinster · founded 2017 · 18 employees$9.4Mraised▾
Provider of personalized, cell-based, autologous, and anti-tumor therapy. The company offers nanoscale biotechnology therapeutic based and used in diagnostic discovery for immunoncology, autoimmune disease, and infectious disease. It also helps in analysis for individual cell function of 10M-1Bn individual living cells for therapeutic design.
- Jun 2022Grant (prize money)$22.9K
- Jul 2021Series A$9.4M
- Sep 2020Grant (prize money)$3M
- Jun 2020Grant (prize money)$2.8M
#4
Series C · Dublin, Leinster · founded 2011 · 35 employees$33.5Mraised▾
Provider of non-viral cell engineering technology platform for drug discovery. The company has developed proprietary technology SOLUPORE that enables the delivery of nucleic acids such as mRNA, DNA, and proteins, including gene-editing tools such as CRISPR to cells and tissues with application in ex vivo and in vivo gene editing.
- Apr 2020Grant (prize money)$542.9K
- Apr 2020Series C$20M
- Apr 2019Angel$13.5M
- May 2018Grant (prize money)$2.5M
#5
Series A · Dublin, Leinster · founded 2015 · 23 employees$3.3Mraised▾
SiriusXT develops X-ray based solutions for 3D imaging of biological cells. Its proprietary SXT system is a soft X-ray microscope that uses vacuum-based laser-produced plasma (LPP) as a source of X-rays. The SXT system is a benchtop instrument that can be used to image the 3D structure of cells in their native, fully hydrated state. Customers include biopharma companies, diagnostics companies and other life science researchers.
- Jan 2021Grant (prize money)$975.1K
- Aug 2020Grant (prize money)$1.8M
- 2020Series A—
- Mar 2017Grant (prize money)$185.3K
#6
Series A · Dublin, Leinster · founded 2009$10.1Mraised▾
Biosortia has a next-generation natural products drug discovery engine focused on identifying therapies in Cancer, CNS, and Infectious Disease. Biosortia's source of the new chemistry is the micro-organisms from the micro-algal environment that is known for its rich chemical diversity and biological activity. The company is discovering & developing new active compounds from unculturable aquatic microorganisms.
- Nov 2019Series A$675K
- Jun 2017Series A$170K
- Dec 2016Series A$2M
- May 2015Series A$1.6M
#7
Deadpooled · Dublin, Leinster · founded 2003 · 50 employees$64Mraised▾
Sigmoid Therapeutics is developing therapies for gastrointestinal and immunological diseases and disorders. The company offers its proprietary oral drug delivery technology named SmPill, to approved drugs or new chemical or biological entities. Its leading product cycol is in phase II is colon-directed cyclosporine ST-0529, to treat ulcerative colitis. Other products include cycron (phase I), a small & large intestine-directed cyclosporine to treat crohn’s disease, allocol (phase I), for controlled release cyclosporine combination to treat graft versus host disease, cylow, which releases cyclosporine for transplant rejection prevention and psoriasis. The company is also affiliated by FDA for the treatment of Crohn's disease.
- May 2018PE$64M
- Mar 2017Grant (prize money)$1.7M
- Jul 2015Grant (prize money)$1.8M
#8
Funding Raised · Galway, Connaught · founded 2015$1.1Mraised▾
Cell Stress Discoveries is dedicated to the development of novel therapeutics in the field of endoplasmic reticulum stress disorders. The company is currently in the very early stages of target validation and is exploring a number of ER stress pathways to develop its targets. The team is also focused on leveraging their expertise to develop biomarkers and assays to assess ER stress and therapeutic efficacy.
- Nov 2019Grant (prize money)$323K
- Feb 2019Grant (prize money)$215.2K
- Jan 2018Grant (prize money)$248.6K
- Jan 2017Grant (prize money)$279.6K
#9
Acquired · Dublin, Leinster · founded 2006 · 17 employees$10Mraised▾
Biosensia is developing a point-of-care in vitro diagnostics platform for immunoassays. RapiPlex comprises of a disposable assay cartridge and a small table top instrument, allowing immunoassays to be conducted at a doctor’s office or a patient's bedside. The cartridge system is compatible with most biological samples, including whole blood, serum, saliva, urine and nasal/genital swabs. Currently, RapiPlex is approved only for research use, and not clinical use.
- Jul 2015Grant (prize money)$730.3K
- Nov 2011Series A$1.6M
- Feb 2008Series A$2.9M
#10
Series A · Dublin, County Dublin · founded 2013 · 5 employees$1.5Mraised▾
Provider and developer of recombinant prokaryotic lectins. Its wide range of RPL products exhibits specificity and sensitivity for glycan epitopes displaying terminal galactose and mannose (including high mannose structures). The RPLs are produced for their use in Diagnostic & Research, Biopharmaceutical, Food Industry, and cosmetics.
- Mar 2020Series A$1M
- Oct 2017Seed$528.8K
- May 2016Seed—
#11
Acquired · Dublin, Leinster · founded 2006 · 7 employees$1.1Mraised▾
Cellix is the manufacturer of microfluidics, biochips, high-throughput cell membrane and gene-editing technology. The company offers software solutions for cell-based assays, cell sorting, and analysis technology and have multiple application in food & beverage, biotech and agri-biotech, and health & personalized medicine, therapeutic research areas like thrombosis, oncology, biofilm culture, stem cell research, sickle cell disease, asthma, and others.
- Dec 2018Grant (prize money)$1.3M
- Jan 2017Grant (prize money)$1.2M
- Feb 2015Grant (prize money)$712.3K
- Feb 2007Seed$1.1M
#12
Series A · Dublin, Leinster · founded 2010 · 10 employees$16.1Mraised▾
Provider of a lipid technology platform for atopic dermatitis. The drug pipeline includes DS107 (topical) for the treatment of atopic dermatitis and pruritus (Phase II); DS107 (oral) for the treatment of atopic dermatitis (Phase II); DS109 which is being developed for undisclosed indications (Phase I). DS107 is a topical formulation of a semi-synthetic omega-6 fatty acid derivative. The company's compounds are based on a proprietary bioactive lipid technology platform that includes semi-synthetic fatty acids.
- Mar 2012Series A$10.7M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth flat
How research on Bioinformatics is moving in Ireland
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 253 Ireland-affiliated papers.
- University College Cork40
- University College Dublin33
- APC Microbiome Institute29
- Ollscoil na Gaillimhe – University of Galway25
- Department of Health24
- Population1→5
- Metagenomics1→4
- Gene2→5
- Transcriptome2→4
- Disease1→8
- In silico1→4
- Disease2→8
Where bioinformatics is researched across Ireland
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.